Cb Scientific Stock Net Income
| CBSC Stock | USD 0.05 0 5.36% |
As of the 8th of February, CB Scientific owns the Standard Deviation of 15.18, market risk adjusted performance of (0.93), and Coefficient Of Variation of 860.51. CB Scientific technical analysis gives you the methodology to make use of past data patterns to determine a pattern that approximates the direction of the entity's future prices.
CB Scientific's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing CB Scientific's valuation are provided below:CB Scientific does not at this moment have any fundamental measures for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. CBSC |
CB Scientific 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CB Scientific's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CB Scientific.
| 11/10/2025 |
| 02/08/2026 |
If you would invest 0.00 in CB Scientific on November 10, 2025 and sell it all today you would earn a total of 0.00 from holding CB Scientific or generate 0.0% return on investment in CB Scientific over 90 days. CB Scientific is related to or competes with Interpace Biosciences, and LFTD Partners. CB Scientific, Inc., through its subsidiaries, provides various products and services in the ambulatory non-invasive car... More
CB Scientific Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CB Scientific's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CB Scientific upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 17.46 | |||
| Information Ratio | 0.1103 | |||
| Maximum Drawdown | 85.0 | |||
| Value At Risk | (20.00) | |||
| Potential Upside | 18.75 |
CB Scientific Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CB Scientific's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CB Scientific's standard deviation. In reality, there are many statistical measures that can use CB Scientific historical prices to predict the future CB Scientific's volatility.| Risk Adjusted Performance | 0.1031 | |||
| Jensen Alpha | 1.9 | |||
| Total Risk Alpha | 0.2532 | |||
| Sortino Ratio | 0.0959 | |||
| Treynor Ratio | (0.94) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of CB Scientific's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
CB Scientific February 8, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1031 | |||
| Market Risk Adjusted Performance | (0.93) | |||
| Mean Deviation | 7.83 | |||
| Semi Deviation | 7.94 | |||
| Downside Deviation | 17.46 | |||
| Coefficient Of Variation | 860.51 | |||
| Standard Deviation | 15.18 | |||
| Variance | 230.45 | |||
| Information Ratio | 0.1103 | |||
| Jensen Alpha | 1.9 | |||
| Total Risk Alpha | 0.2532 | |||
| Sortino Ratio | 0.0959 | |||
| Treynor Ratio | (0.94) | |||
| Maximum Drawdown | 85.0 | |||
| Value At Risk | (20.00) | |||
| Potential Upside | 18.75 | |||
| Downside Variance | 305.01 | |||
| Semi Variance | 63.09 | |||
| Expected Short fall | (19.11) | |||
| Skewness | 2.6 | |||
| Kurtosis | 11.87 |
CB Scientific Backtested Returns
CB Scientific is out of control given 3 months investment horizon. CB Scientific retains Efficiency (Sharpe Ratio) of 0.12, which signifies that the company had a 0.12 % return per unit of price deviation over the last 3 months. We are able to interpolate and collect twenty-six different technical indicators, which can help you to evaluate if expected returns of 1.76% are justified by taking the suggested risk. Use CB Scientific Standard Deviation of 15.18, coefficient of variation of 860.51, and Market Risk Adjusted Performance of (0.93) to evaluate company specific risk that cannot be diversified away. CB Scientific holds a performance score of 9 on a scale of zero to a hundred. The firm owns a Beta (Systematic Risk) of -1.87, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning CB Scientific are expected to decrease by larger amounts. On the other hand, during market turmoil, CB Scientific is expected to outperform it. Use CB Scientific semi deviation, sortino ratio, semi variance, as well as the relationship between the information ratio and value at risk , to analyze future returns on CB Scientific.
Auto-correlation | -0.37 |
Poor reverse predictability
CB Scientific has poor reverse predictability. Overlapping area represents the amount of predictability between CB Scientific time series from 10th of November 2025 to 25th of December 2025 and 25th of December 2025 to 8th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CB Scientific price movement. The serial correlation of -0.37 indicates that just about 37.0% of current CB Scientific price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.37 | |
| Spearman Rank Test | -0.04 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, CB Scientific reported net income of (6.34 Million). This is 101.86% lower than that of the Healthcare sector and 106.37% lower than that of the Medical Instruments & Supplies industry. The net income for all United States stocks is 101.11% higher than that of the company.
CBSC Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CB Scientific's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of CB Scientific could also be used in its relative valuation, which is a method of valuing CB Scientific by comparing valuation metrics of similar companies.CB Scientific is currently under evaluation in net income category among its peers.
CBSC Fundamentals
| Operating Margin | (14.86) % | |||
| Current Valuation | 20.95 M | |||
| Shares Outstanding | 120.03 M | |||
| Price To Book | 261.27 X | |||
| Price To Sales | 456.11 X | |||
| Revenue | 75.58 K | |||
| Gross Profit | 23.49 K | |||
| EBITDA | (4.8 M) | |||
| Net Income | (6.34 M) | |||
| Cash And Equivalents | 4.67 K | |||
| Current Ratio | 0.03 X | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (786.03 K) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | 0.71 | |||
| Market Capitalization | 22.45 M | |||
| Total Asset | 653.97 K | |||
| Z Score | -23.1 | |||
| Net Asset | 653.97 K |
About CB Scientific Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CB Scientific's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CB Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CB Scientific based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in CBSC Pink Sheet
CB Scientific financial ratios help investors to determine whether CBSC Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CBSC with respect to the benefits of owning CB Scientific security.